An immunocompetent murine model for oncolysis with an armed and targeted measles virus. (Q40090948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

An immunocompetent murine model for oncolysis with an armed and targeted measles virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

1 reference

Guy Ungerechts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Marie E Frenzke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Johanna Lampe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

William B Parker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Eric J Sorscher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

21 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1991-1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

Recent progress in the battle between oncolytic viruses and tumours

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

China approves world's first oncolytic virus therapy for cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Systemic therapy of myeloma xenografts by an attenuated measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Measles virus: cellular receptors, tropism and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Recombinant measles viruses efficiently entering cells through targeted receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Disruption of Akt kinase activation is important for immunosuppression induced by measles virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

STAT protein interference and suppression of cytokine signal transduction by measles virus V protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Engineering oncolytic measles virus to circumvent the intracellular innate immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Cell to Cell Contact Is Not Required for Bystander Cell Killing by Escherichia coli Purine Nucleoside Phosphorylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Experimental Measles. II. Infection and Immunity in the Rhesus Macaque

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300291

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json

release_2s6sh5zqsbegbkxqx6xtoyavgu

3 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2s6sh5zqsbegbkxqx6xtoyavgu

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17712331%20AND%20SRC:MED&resulttype=core&format=json